2019
DOI: 10.1002/ajim.23001
|View full text |Cite
|
Sign up to set email alerts
|

Response to Paustenbach

Abstract: Dr. Paustenbach's letter begins with an ad hominem attack, "Given his (Dr. Egilman's) history in the courtroom, it seems that the editor would be especially cautious." 1 The citations for this sentence refer first to my release of previously secret documents and information on pharmaceutical giant Ely Lilly's marketing practices, which were causing deaths in elderly dementia patients. 2 The release of these documents resulted in three front-page New York Times stories and spurred a Justice Department investiga… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 33 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?